Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, randomized, open-label, two-period,cross-over trial
Status
Status :
Completed
Type of study
Phase IV
Min. Age
18
Years old
Max. Age
64
Years old
Gender
Female
Therapeutic area :
Rhumatology
Disease :
Healthy subjects
Study medication :
L0006
Phase :
Phase IV
Start Date :
09 September 2008
End date :
13 January 2009
Study ID :
L00006 CP 403 3A
EudraCT/CTIS number :
2008-002280-14
Send by email